Personal information

Other IDs

Scopus Author ID: 57190309730

Activities

Collapse all

Works (8)

Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer

Future Oncology
2023-11-15 | Journal article
DOI: 10.2217/fon-2023-0111
Part of ISSN: 1479-6694
Part of ISSN: 1744-8301
Contributors: Louise Faaborg; Rikke Fredslund Andersen; Sara WC Wen; Caroline B Thomsen; Louise Raunkilde; Torben Frøstrup Hansen; Lars Henrik Jensen; Karina Dahl Steffensen; Anders Jakobsen
Source: Self-asserted source
Louise Raunkilde

Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study

Acta Oncologica
2023-09-02 | Journal article | Author
DOI: 10.1080/0284186x.2023.2249225
Part of ISSN: 0284-186X
Part of ISSN: 1651-226X
Contributors: Louise Raunkilde; Torben Hansen; Birgitte Mayland Havelund ; Caroline Emilie Brenner Thomsen; Rafaelsen S; Jan Lindebjerg; Lars Henrik Jensen
Source: Self-asserted source
Louise Raunkilde

<i>NPY</i> Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer

Cancers
2022-09 | Journal article | Author
DOI: 10.3390/cancers14184459
Contributors: Louise Raunkilde; Torben Hansen; Rikke Fredslund Andersen; Birgitte Mayland Havelund; Caroline Emilie Brenner Thomsen; Lars Henrik Jensen
Source: check_circle
Multidisciplinary Digital Publishing Institute

The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab

Cancers
2022-09 | Journal article | Author
DOI: 10.3390/cancers14194598
Contributors: Line Bechsgaard Andersen; Marit Sofie Kjær Mahler; Rikke Fredslund Andersen; Lars Henrik Jensen; Louise Raunkilde
Source: check_circle
Multidisciplinary Digital Publishing Institute

Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer

Translational Oncology
2019 | Journal article
DOI: 10.1016/j.tranon.2019.04.002
EID:

2-s2.0-85065627296

Part of ISBN:

19365233
Contributors: Hansen, T.F.; Nederby, L.; Zedan, A.H.; Mejlholm, I.; Henriksen, J.R.; Steffensen, K.D.; Thomsen, C.B.; Raunkilde, L.; Jensen, L.H.; Jakobsen, A.
Source: Self-asserted source
Louise Raunkilde via Scopus - Elsevier

Immunterapi er kræftbehandling med en helt ny bivirkningsprofil

Ugeskrift for Laeger
2018 | Journal article
EID:

2-s2.0-85048987622

Part of ISBN:

00415782
Contributors: Kondrup, M.; Raunkilde, L.; Svane, I.M.; Schmidt, H.; Bastholt, L.
Source: Self-asserted source
Louise Raunkilde via Scopus - Elsevier

Immunotherapy is cancer treatment with a novel side-effect profile

Ugeskrift for laeger
2017 | Journal article
EID:

2-s2.0-85060163187

Part of ISBN:

16036824
Contributors: Kondrup, M.; Raunkilde, L.; Svane, I.M.; Schmidt, H.; Bastholt, L.
Source: Self-asserted source
Louise Raunkilde via Scopus - Elsevier

Imaging of hepatic angiosarcoma,Hepatisk angiosarkom som billeddiagnostisk differentialdiagnose til atypisk hæmangiom

Ugeskrift for laeger
2014 | Journal article
EID:

2-s2.0-84979093761

Part of ISBN:

16036824
Contributors: Raunkilde, L.; Brodersen, L.R.; Rafaelsen, S.A.
Source: Self-asserted source
Louise Raunkilde via Scopus - Elsevier
How many people are using ORCID?